Danish Mahmood
Metabolic syndrome (MS) is a clustering of metabolic and underlying risk factors which doubles the risk of atherosclerotic cardiovascular disease. It is more prevalent in some ethnic groups, especially in the Asian world.
Global urbanization and sedentary life habits have increased the underlying risk factors characterised by physical inactivity, atherogenic diet and obesity. Therefore, its detection, prevention, and treatment serve as an important approach for the reduction of cardiovascular risk in the general population and strictly emphasized on strict therapeutic lifestyle changes.
In our case report, we present effective management of a dyslipidaemic patient with MS by medication. However, her underlying risk factors were not controlled due to her inability to strictly adopt therapeutic lifestyle changes.